Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 5
2006 4
2007 8
2008 4
2009 4
2010 6
2011 7
2012 1
2013 3
2014 8
2015 5
2016 3
2017 3
2018 4
2019 7
2020 3
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19126569

66 results

Results by year

Filters applied: . Clear all
Page 1
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome.
Berry-Kravis E, Hessl D, Coffey S, Hervey C, Schneider A, Yuhas J, Hutchison J, Snape M, Tranfaglia M, Nguyen DV, Hagerman R. Berry-Kravis E, et al. J Med Genet. 2009 Apr;46(4):266-71. doi: 10.1136/jmg.2008.063701. Epub 2009 Jan 6. J Med Genet. 2009. PMID: 19126569 Free PMC article. Clinical Trial.
Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results.
Youssef EA, Berry-Kravis E, Czech C, Hagerman RJ, Hessl D, Wong CY, Rabbia M, Deptula D, John A, Kinch R, Drewitt P, Lindemann L, Marcinowski M, Langland R, Horn C, Fontoura P, Santarelli L, Quiroz JA; FragXis Study Group. Youssef EA, et al. Neuropsychopharmacology. 2018 Feb;43(3):503-512. doi: 10.1038/npp.2017.177. Epub 2017 Aug 17. Neuropsychopharmacology. 2018. PMID: 28816242 Free PMC article. Clinical Trial.
Open-label riluzole in fragile X syndrome.
Erickson CA, Weng N, Weiler IJ, Greenough WT, Stigler KA, Wink LK, McDougle CJ. Erickson CA, et al. Brain Res. 2011 Mar 22;1380:264-70. doi: 10.1016/j.brainres.2010.10.108. Epub 2010 Nov 5. Brain Res. 2011. PMID: 21059347 Clinical Trial.
Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity.
Porter RH, Jaeschke G, Spooren W, Ballard TM, Büttelmann B, Kolczewski S, Peters JU, Prinssen E, Wichmann J, Vieira E, Mühlemann A, Gatti S, Mutel V, Malherbe P. Porter RH, et al. J Pharmacol Exp Ther. 2005 Nov;315(2):711-21. doi: 10.1124/jpet.105.089839. Epub 2005 Jul 22. J Pharmacol Exp Ther. 2005. PMID: 16040814
Brief report: acamprosate in fragile X syndrome.
Erickson CA, Mullett JE, McDougle CJ. Erickson CA, et al. J Autism Dev Disord. 2010 Nov;40(11):1412-6. doi: 10.1007/s10803-010-0988-9. J Autism Dev Disord. 2010. PMID: 20213249
66 results